Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trialXiaotian Zhang, Jiafu Ji, Xiangqian Su et al.|The Lancet Oncology|2021Cited by 436
Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomised, controlled, phase 3, superiority trialLai Xu, Xiangqian Su, Zirui He et al.|The Lancet Oncology|2021Cited by 184
Short-term surgical outcomes of laparoscopy-assisted versus open D2 distal gastrectomy for locally advanced gastric cancer in North China: a multicenter randomized controlled trialZaozao Wang, Xiangqian Su, Jiadi Xing et al.|Surgical Endoscopy|2018Cited by 100
KIF14 promotes cell proliferation via activation of Akt and is directly targeted by miR-200c in colorectal cancerZaozao Wang, Xiangqian Su|International Journal of Oncology|2018Cited by 59
STK25-induced inhibition of aerobic glycolysis via GOLPH3-mTOR pathway suppresses cell proliferation in colorectal cancerFan Wu, Xiangqian Su|Journal of Experimental & Clinical Cancer Research|2018Cited by 38